Phone: +385 1 8886300

Email: fidelta@glpg.com

ADME / PK

Apply Fidelta's comprehensive in vitro ADME, pharmacokinetic and bioanalytical services to assist and guide medicinal chemistry programs in hit-to-lead and lead optimization phases of drug discovery.
MEET US AT EVENTS ASK OUR EXPERTS ADME / PK VIDEO SUBSCRIBE TO OUR NEWSLETTER Your privacy is important to us. ADME / PK a:5:{i:0;s:25:"Integrated Drug Discovery";i:… http://www.fidelta.eu/services/adme-pk/

Cytochrome P450 Inhibition in Human Liver Microsomes

Inhibition of CYP450 enzymes is a principal mechanism of metabolism-based drug-drug interactions and a common cause of adverse drug events.
http://www.fidelta.eu/resources/data-sheets/adme-pk/cytochrome-p450-inhibition-in-human-liver-microsomes/

© 2015 All Rights Reserved - Fidelta Ltd.